Pharmacokinetics of vancomycin in critically Ill children: A systematic review

Simple item page
dc.contributor.authorOnyinye Onyeka, Akunne
dc.date.accessioned2022-09-27T14:22:21Z
dc.date.available2022-09-27T14:22:21Z
dc.date.issued2021
dc.description.abstractBackground and Objective Vancomycin is often used in the ICU for the treatment of Gram-positive bacterial infection. In critically ill children, there are pathophysiologic changes that afect the pharmacokinetics of vancomycin. A systematic review of vancomycin pharmacokinetics and pharmacodynamics in critically ill children was performed. Methods Pharmacokinetic studies of vancomycin in critically ill children published up to May 2021 were included in the review provided they included children aged > 1 month. Studies including neonates were excluded. A search was performed using the PubMed, Scopus, and Google Scholar databases. The Risk of Bias Assessment Tool for Systematic Reviews (ROBIS) was used to check for quality and reduce bias. Data on study characteristics, patient demographics, clinical parameters, pharmacokinetic parameters, outcomes, and study limitations were collected. Results Thirteen studies were included in this review. A wide variety of dosing and sampling strategies were used in the studies. Methods for estimating vancomycin pharmacokinetics, especially the area under the curve over 24 h, varied. Vancomycin doses of 20–60 mg/kg were given daily. This resulted in high variability in pharmacokinetic parameters. Vancomycin trough level was less than 15 μg/mL in most of the studies. Vancomycin clearance ranged from 0.05 to 0.38 L/h/kg. Volume of distribution ranged from 0.1 to 1.16 L/kg. Half-life was between 2.4 and 23.6 h. Patients in the study receiving continuous vancomycin infusion had AUC24 < 400 µg·h/mL. Conclusion There is large variability in the pharmacokinetics of vancomycin among critically ill patients. Studies to assess the factors responsible for this variability in vancomycin pharmacokinetics are needed.en_US
dc.identifier.citationAkunne, O. O., Mugabo, P., & Argent, A. C. (2022). Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review. European journal of drug metabolism and pharmacokinetics, 47(1), 31–48. https://doi.org/10.1007/s13318-021-00730-zen_US
dc.identifier.urihttps://doi.org/10.1007/s13318-021-00730-z
dc.identifier.urihttp://hdl.handle.net/10566/7975
dc.language.isoenen_US
dc.publisherEuropean journal of drug metabolism and pharmacokineticsen_US
dc.subjectpharmacokineticsen_US
dc.subjectvancomycinen_US
dc.subjectIll childrenen_US
dc.titlePharmacokinetics of vancomycin in critically Ill children: A systematic reviewen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Pharmacokinetics of Vancomycin in Critically Ill Children.pdf
Size:
841.05 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles (School of Pharmacy)